Dolby Laboratories, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 10.0% of Dolby Laboratories, Inc.'s Class A Stock as of May 31, 2026.
NYSE
Morgan Stanley and Atlanta Capital Management Company, LLC have filed a Schedule 13G, reporting beneficial ownership of Dolby Laboratories, Inc. Class A Common Stock.
NYSE
Vanguard Capital Management has filed a Schedule 13G reporting a 5.24% beneficial ownership stake in Dolby Laboratories Inc.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 8.24% in Dolby Laboratories Inc. common stock as of March 31, 2026.
NYSE
SCHEDULE: BNY Mellon Entities Adjust Dolby Stake
Several BNY Mellon entities have updated their beneficial ownership filings for Dolby Laboratories, Inc. Class A Common Stock.
NYSE
The Vanguard Group, Inc. has amended its Schedule 13G filing for Dolby Laboratories Inc., reporting 0% beneficial ownership due to an internal reporting realignment.
NYSE
Morgan Stanley and its affiliates have reported a significant beneficial ownership stake of 10.2% in Dolby Laboratories, Inc. Class A Common Stock.
NYSE
The Vanguard Group has filed an amended Schedule 13G, disclosing its beneficial ownership of 12.31% of Dolby Laboratories Inc.'s common stock as of March 31, 2025.
NYSE
Bank of New York Mellon Corporation and its subsidiaries have filed an amended Schedule 13G, disclosing their beneficial ownership of 9.3% of Dolby Laboratories, Inc.'s Class A Common Stock as of March 31, 2025.
NYSE
Bank of New York Mellon Corp and its subsidiaries report beneficial ownership of 4,826,477 shares, representing 8.0% of Dolby Laboratories' Class A Common Stock as of December 31, 2024.